FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412077000: Adrenal hormone agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Adrenal hormone agent Is a Adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Has disposition Adrenal hormone (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a Hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Triamcinolone acetate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate monohydrate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Corticosteroids for oropharynx The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Topical form corticosteroids The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone lotions/dressng The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone compound preprations The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone+antimicrobials The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone/neomycin cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone diprop [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone + antimicrobials The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Stiedex LPN oily cream 15g The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide Topical The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate [topical] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate[skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Corticosteroids [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Corticosteroids cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Stiedex LPN oily cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Respiratory mometasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing mometasone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 400micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 200micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing dexamethasone and tobramycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 400micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 200micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 50micrograms CFC-free breath-actuated aerosol inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 100micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 100micrograms CFC-free breath-actuated aerosol inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 1% aqueous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol+hydrocortisone 3%/0.5% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Flunisolide 250mcg/inh inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Iodoquinol+hydrocortisone 1%/1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Halobetasol propionate 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Halobetasol propionate 0.05% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone cypionate 10mg/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluorometholone acetate 0.1% suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Rimexolone 1% suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 1% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone acetate 8 mg/mL suspension for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 10 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone diacetate 40 mg/mL suspension for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium su 125mg/2mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium su 40mg/mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone valerate 0.12% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone valerate 0.12% aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate 2 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Amcinonide 1 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflorasone diacetate 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflorasone diacetate 0.05% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 42mcg aerosol (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Flunisolide 250mcg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Flunisolide 0.025% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Flurandrenolide 4mcg/sq/cm tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Flurandrenolide 4mcg tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 500 microgram/mL cutaneous lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone acetate 8mg/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 40mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 125mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 1g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 500mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 2g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone valerate 2 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.05% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.05% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone diacetate 25mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone diacetate 40mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone acetate 16mg/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 500g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate0.5% ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium su 40mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 220mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 110mcg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 110mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 44mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 125mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 42mcg inhaler (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone valerate) 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 55mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 200mcg/spr The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 6 of 9 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start